Saturday, February 2, 2019

Commonly used anti-rejection drug could be repurposed to treat some liver cancers

Research in animal models and patient tissues has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be repurposed to treat certain liver cancers.

from Top Health News -- ScienceDaily http://bit.ly/2MK3wwq

No comments:

Post a Comment

Researchers tested AI against 100,000 humans on creativity

A massive new study comparing more than 100,000 people with today’s most advanced AI systems delivers a surprising result: generative AI can...